日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/06/20 | 5,440 | 5,440 | 5,310 | 5,340 | -40 | -0.7% | 412,900 |
| 2016/06/17 | 5,480 | 5,500 | 5,380 | 5,380 | -90 | -1.6% | 378,600 |
| 2016/06/16 | 5,650 | 5,690 | 5,460 | 5,470 | -210 | -3.7% | 157,300 |
| 2016/06/15 | 5,570 | 5,710 | 5,560 | 5,680 | +10 | +0.2% | 193,900 |
| 2016/06/14 | 5,700 | 5,730 | 5,580 | 5,670 | -80 | -1.4% | 189,200 |
| 2016/06/13 | 5,790 | 5,830 | 5,700 | 5,750 | -160 | -2.7% | 165,600 |
| 2016/06/10 | 5,840 | 5,910 | 5,800 | 5,910 | -30 | -0.5% | 233,600 |
| 2016/06/09 | 5,890 | 5,960 | 5,870 | 5,940 | +10 | +0.2% | 99,500 |
| 2016/06/08 | 5,840 | 5,930 | 5,810 | 5,930 | +40 | +0.7% | 193,900 |
| 2016/06/07 | 5,800 | 5,910 | 5,760 | 5,890 | +80 | +1.4% | 198,900 |
| 2016/06/06 | 5,740 | 5,810 | 5,680 | 5,810 | -20 | -0.3% | 213,700 |
| 2016/06/03 | 5,850 | 5,930 | 5,800 | 5,830 | +10 | +0.2% | 219,100 |
| 2016/06/02 | 5,840 | 5,930 | 5,740 | 5,820 | -40 | -0.7% | 179,900 |
| 2016/06/01 | 5,800 | 5,920 | 5,780 | 5,860 | -10 | -0.2% | 230,400 |
| 2016/05/31 | 5,890 | 5,930 | 5,830 | 5,870 | -90 | -1.5% | 344,800 |
| 2016/05/30 | 5,630 | 6,040 | 5,600 | 5,960 | +460 | +8.4% | 550,100 |
| 2016/05/27 | 5,530 | 5,570 | 5,480 | 5,500 | +10 | +0.2% | 187,900 |
| 2016/05/26 | 5,480 | 5,530 | 5,430 | 5,490 | +110 | +2% | 238,100 |
| 2016/05/25 | 5,490 | 5,500 | 5,370 | 5,380 | -80 | -1.5% | 258,800 |
| 2016/05/24 | 5,370 | 5,500 | 5,360 | 5,460 | +90 | +1.7% | 305,200 |
| 2016/05/23 | 5,350 | 5,420 | 5,300 | 5,370 | +100 | +1.9% | 404,600 |
| 2016/05/20 | 5,300 | 5,350 | 5,230 | 5,270 | -110 | -2% | 473,200 |
| 2016/05/19 | 5,400 | 5,400 | 5,280 | 5,380 | -40 | -0.7% | 306,000 |
| 2016/05/18 | 5,400 | 5,590 | 5,370 | 5,420 | +140 | +2.7% | 530,800 |
| 2016/05/17 | 5,230 | 5,300 | 5,180 | 5,280 | +100 | +1.9% | 277,800 |
| 2016/05/16 | 5,290 | 5,310 | 5,170 | 5,180 | -110 | -2.1% | 251,700 |
| 2016/05/13 | 5,300 | 5,320 | 5,220 | 5,290 | +270 | +5.4% | 431,400 |
| 2016/05/12 | 5,030 | 5,090 | 4,985 | 5,020 | -80 | -1.6% | 142,900 |
| 2016/05/11 | 5,070 | 5,120 | 4,985 | 5,100 | +30 | +0.6% | 167,300 |
| 2016/05/10 | 4,965 | 5,120 | 4,965 | 5,070 | +150 | +3% | 233,000 |
| 2016/05/09 | 4,895 | 4,935 | 4,840 | 4,920 | +10 | +0.2% | 214,800 |
| 2016/05/06 | 4,960 | 5,010 | 4,865 | 4,910 | +20 | +0.4% | 339,600 |
| 2016/05/02 | 4,785 | 4,910 | 4,770 | 4,890 | -105 | -2.1% | 408,600 |
| 2016/04/28 | 5,080 | 5,090 | 4,910 | 4,995 | -125 | -2.4% | 540,900 |
| 2016/04/27 | 5,060 | 5,270 | 5,020 | 5,120 | +130 | +2.6% | 373,200 |
| 2016/04/26 | 5,040 | 5,100 | 4,925 | 4,990 | -150 | -2.9% | 680,800 |
| 2016/04/25 | 5,200 | 5,210 | 5,120 | 5,140 | -110 | -2.1% | 279,400 |
| 2016/04/22 | 5,050 | 5,250 | 5,040 | 5,250 | +230 | +4.6% | 759,000 |
| 2016/04/21 | 4,945 | 5,040 | 4,920 | 5,020 | +160 | +3.3% | 543,700 |
| 2016/04/20 | 4,900 | 4,955 | 4,820 | 4,860 | -10 | -0.2% | 344,800 |
| 2016/04/19 | 4,870 | 4,870 | 4,790 | 4,870 | +130 | +2.7% | 220,800 |
| 2016/04/18 | 4,695 | 4,810 | 4,680 | 4,740 | -85 | -1.8% | 190,300 |
| 2016/04/15 | 4,730 | 4,850 | 4,730 | 4,825 | -30 | -0.6% | 348,100 |
| 2016/04/14 | 4,790 | 4,860 | 4,745 | 4,855 | +135 | +2.9% | 401,900 |
| 2016/04/13 | 4,600 | 4,745 | 4,590 | 4,720 | +180 | +4% | 359,000 |
| 2016/04/12 | 4,595 | 4,660 | 4,510 | 4,540 | -10 | -0.2% | 285,000 |
| 2016/04/11 | 4,485 | 4,565 | 4,440 | 4,550 | +25 | +0.6% | 231,400 |
| 2016/04/08 | 4,410 | 4,550 | 4,355 | 4,525 | +20 | +0.4% | 309,500 |
| 2016/04/07 | 4,410 | 4,535 | 4,380 | 4,505 | +195 | +4.5% | 422,400 |
| 2016/04/06 | 4,275 | 4,320 | 4,230 | 4,310 | +65 | +1.5% | 334,700 |
2201～
2250
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 340,000円 | +8.0% | -15.3% | 3.65% | 9.55倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 412,500円 | +5.8% | +1.2% | 2.91% | 13.68倍 | 1.09倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 334,900円 | +3.8% | -19.9% | 4.06% | 10.88倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 186,400円 | +5.9% | +684.6% | 2.95% | 12.37倍 | 1.24倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 163,300円 | +5.0% | +1.5% | 0.00% | 13.97倍 | 3.72倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
